NewGenIvf (NIVF) Total Current Liabilities (2022 - 2025)

NewGenIvf has disclosed Total Current Liabilities across 4 years of filings, most recently posting $2.4 million for Q4 2025.

• In Q4 2025, Total Current Liabilities fell 13.01% year-over-year to $2.4 million; the TTM figure through Dec 2025 stood at $2.4 million (down 13.01% YoY), while the FY2025 annual figure was $2.4 million, down 13.01% from the prior year.
• Total Current Liabilities fell to $2.4 million in Q4 2025, from $1621.0 billion in the prior quarter.
• Over the last five years, Total Current Liabilities for NIVF reached as high as $1621.0 billion in Q3 2025 and fell as low as $1.1 million in Q4 2023.
• The 4-year median for Total Current Liabilities is $2.5 million (2022), against an average of $270.2 billion.
• Annual changes were most pronounced in 2023 — Total Current Liabilities plunged 56.08% — and 2024, when it jumped 142.36%.
• A 4-year view of Total Current Liabilities shows it stood at $2.6 million in 2022, then tumbled by 56.08% to $1.1 million in 2023, then jumped by 142.36% to $2.7 million in 2024, then retreated by 13.01% to $2.4 million in 2025.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $2.4 million, $1621.0 billion, and $2.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.